Implementation of transmission NIR as a PAT tool for monitoring drug transformation during HME processing by Islam, Muhammad T. et al.
Strathprints Institutional Repository
Islam, Muhammad T. and Scoutaris, Nikolaos and Maniruzzaman, 
Mohammed and Moradiya, Hiren G. and Halsey, Sheelagh A. and Bradley, 
Michael S.A. and Chowdhry, Babur Z. and Snowden, Martin J. and 
Douroumis, Dennis (2015) Implementation of transmission NIR as a PAT 
tool for monitoring drug transformation during HME processing. 
European Journal of Pharmaceutics and Biopharmaceutics, 96. pp. 106-
116. ISSN 0939-6411 , http://dx.doi.org/10.1016/j.ejpb.2015.06.021
This version is available at http://strathprints.strath.ac.uk/55950/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (http://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any  correspondence  concerning  this  service  should  be  sent  to  Strathprints  administrator: 
strathprints@strath.ac.uk
 Implementation of transmission NIR as a PAT 
tool for monitoring drug transformation during 
HME processing 
 
Muhammad T. Islama, Nikolaos Scoutarisa, Mohammed Maniruzzamana, Hiren G. 
Moradiyaa, Sheelagh A. Halseyb, Michael Bradleya, Babur Z. Chowdhrya, Martin J. 
Snowdena, Dennis Douroumisa* 
 
aFaculty of Engineering and Science, University of Greenwich, Medway Campus, 
Chatham Maritime, Kent ME4 4TB, UK 
bThermoFisher Scientific, Stafford House, Boundary Way, Hemel Hempstead HP2 7GE, UK 
 
 
 
 
 
 
 
 
 
Abbreviations: API, active pharmaceutical ingredients;  DSC, differential scanning 
calorimetry; FDA, Food and Drug Administration; HME, hot-melt extrusion; IND, 
indomethacin; NIR, near infrared spectroscopy; PAT, process analytical technology;        
PCA, principal component analysis; QbD, Quality by design; SOL, soluplus; VA64, Kollidon 
VA 64; XRPD, x-ray powder diffraction. 
 
 
 
                                                 
* Corresponding author, Department of Pharmaceutical, Chemical & Environmental Sciences, Faculty of 
Engineering and Science, University of Greenwich, Medway Campus, Chatham Maritime, Kent ME4 4TB, UK. 
Tel.: +44 (0) 208 331 8440; Fax: +44 (0) 208 331 9805. 
E-mail address: D.Douroumis@gre.ac.uk (D. Douroumis). 
 
 ABSTRACT 
The aim of the work reported herein was to implement process analytical technology (PAT) 
tools during hot melt extrusion (HME) in order to obtain a better understanding of the 
relationship between HME processing parameters and the extruded formulations. For the first 
time two in-line NIR probes (transmission and reflectance) have been coupled with HME to 
monitor the extrusion of the water insoluble drug indomethacin (IND) in the presence of 
Soluplus (SOL) or Kollidon VA64 hydrophilic polymers. In-line extrusion monitoring of 
sheets, produced via a specially designed die, was conducted at various drug/polymer ratios 
and processing parameters. Characterization of the extruded transparent sheets was also 
undertaken by using DSC, XRPD and Raman mapping. Analysis of the experimental findings 
revealed the production of molecular solutions where IND is homogeneously blended 
(ascertained by Raman mapping) in the polymer matrices, as it acts as a plasticizer for both 
hydrophilic polymers. PCA analysis of the recorded NIR signals showed that the screw speed 
used in HME affects the recorded spectra but not the homogeneity of the embedded drug in 
the polymer sheets. The IND/VA64 and IND/SOL extruded sheets displayed rapid 
dissolution rates with 80% and 30% of the IND being released, respectively within the first 
20 min.  
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1. Introduction 
Hot melt extrusion (HME) is an emerging processing technology for the development of 
solid drug dispersions embedded in a carrier matrix for the development of oral solid dosage 
pharmaceutical forms [1-5]. The technique has been adopted in pharmaceutical research due 
to its versatility and the several advantages that it offers compared to traditional 
manufacturing techniques. For example, HME is solvent free, a wide range of excipients can 
be processed, it is cost effective, and can be easily scaled-up with high throughput and 
operated in continuous mode [6]. HME has been utilized to enhance the dissolution rate of 
APIs by preparing solid dispersions [7, 8] where the drug is molecularly dispersed in the 
polymer matrix which leads to improved bioavailability [9]. Repka et al, utilized HME to 
prepare bioadhesive films with increased dissolution rates of poorly water-soluble drugs by 
exploring the influence of processing parameters [10-12]. The developed films were used for 
pharmaceutical and denture applications using transmucosal delivery. Sun et al. prepared a 
semi-solid capsule containing a solid dispersion of nimodipine processed with Eudragit® 
E100 and Plasdone® S630 using a twin-screw extruder [13]. The extruded solid dispersion 
was formulated into gelatine capsules followed by in vivo studies in beagle dogs and 
compared with a marketed product of the same drug. The in vivo comparison revealed faster 
absorption of nimodipine for the hot-melt extruded formulations compared to the marketed 
product.  
The Food and Drug Administration (FDA) introduced the concept of Process Analytical 
Technologies (PAT) in 2004 for a better fundamental scientific understanding of 
manufacturing processes [14, 15] and to ensure the final quality of the end product. The aim 
of this initiative is to implement appropriate measurement tools, which can be placed at/in or 
on-line for monitoring and data analysis via a scientific approach such as chemometrics and 
Quality by Design (QbD) approach to ensure production of in-process materials and the final 
quality of products [16]. 
HME is among the technologies that can be coupled with PAT tools for the development 
of pharmaceutical solid dosage forms. In-line reflectance NIR and in-line Raman 
spectroscopy have also been used as PAT tools in order to understand drug-polymer 
interactions and to validate a method for continuous API quantification during HME 
processing [17-18]. The application of in-line NIR spectroscopy to monitor the extrusion 
process was demonstrated by Fischer et al [19] who successfully determined the content of 
ethylene vinyl acetate in a polypropylene matrix. Off-line and in-line reflectance NIR has 
also been used to monitor the formation of carbamazepine-saccharine [20] and 
carbamazepine-trans-cinnamic acid [21] cocrystals.. However, reflectance NIR contains large 
amount of noise in the spectra when monitoring a transparent formulation. In contrast, 
transmission NIR has also been reported for studies of single screw polymer extrusion of low 
[22] and high [23] density polyethylene/polypropylene co-polymers. The use of transmission 
NIR for the characterization of an API extrusion processed via HME has not been reported. 
Using NIR as a non-destructive on-line monitoring tool for the impact of critical process 
parameters (feed-rate, screw speed, temperature) improves process efficiency and product 
quality as adjustments to the process can be made in real time when deviations in the process 
are detected during HME. This was shown by Coates et al [23] for polyethylene-propylene 
blends where rapid and accurate determination of the ethylene content is essential. Thus it is 
important to employ an analytical method, such as transmission NIR, for monitoring 
transparent extrudates of an API produced by HME [17]. 
In this study, a transmission NIR probe was used for in-line monitoring of transparent 
extruded sheet formulations; the NIR probe was inserted in a specially designed extrusion 
die. In addition HME processing was coupled with both transmission and reflectance NIR 
probes in order to provide a more detailed understanding of the physical transformations of 
the drug during extrusion. For the purposes of the study, indomethacin (IND) was extruded 
with the hydrophilic polymers Soluplus (SOL) or Kollidon VA64 (VA64) at various 
drug/polymer ratios. Previous studies showed that the extrusion of IND with these polymers 
leads to the production of molecular solutions with improved drug dissolution rates compared 
to the bulk drug [9]. 
 
2. Materials and methods 
2.1. Materials 
Indomethacin (IND) was supplied by Tokyo Chemical Industry Co. Ltd (Tokyo, Japan), 
Soluplus (polyvinyl caprolactam-polyvinyl acetate-polyvinyl-glycol graft copolymer) and 
Kollidon VA64 (vinylpyrrolidone-vinyl acetate copolymer) were kindly donated by BASF 
(Ludwigshafen, Germany). HPLC solvents (acetonitrile, acetic acid) were of analytical grade 
and purchased from Fisher Scientific (Loughborough, UK). All chemicals were used as 
received. 
2.2. Hot-melt extrusion process 
HME was performed by using a Eurolab 16 mm twin screw extruder (Thermo Fisher 
Scientific, Karlsruhe, Germany). The HME extruder was equipped with a DD Flexwall® 18 
volumetric feeder (Brabender Technology, Duisburg, Germany). Seven different 
formulations of IND/SOL and IND/VA64, at different weight ratios, were extruded (Table 1). 
Prior to HME, drug-polymer batches (300g) were blended in a Turbula TF2 mixer (100 rpm) 
(Basel, Switzerland) for 10 min in order to obtain a homogeneous mix. The barrel 
temperature profile was set at 50/100/120/135/145/150/150/150/140qC (from feeder to die) 
for batches F1-F5 and at 50/100/120/150/150/150/150/150/140qC for formulations F6 and 
F7. A newly manufactured transmission die (Fig. 1A.) was fitted at the end of the extruder 
barrel in order to collect in-line transmission NIR spectra (Fig. 2). The die was made of 
stainless steel, with a 1 mm die opening where the transmission NIR probe can be inserted 
and the distance between the incident and the transmitted radiation is therefore 1 mm (slit 
size) so that the infra-red radiation can pass through the transparent extrudates and be 
transmitted to the NIR detector.  
The extruded sheets were fed continuously to a cutter mill (Cutting Mill SM 100, Retsch, 
Uk) for further micronization with constant rotating speed. A 250 µM sieve was placed at the 
bottom of the casing holds to control the size of the material discharged from the milling 
zone. 
 
2.3. Thermal analysis 
The physical state of bulk IND, the physical mixtures and the extruded granules was 
analysed by DSC using a Mettler-Toledo 823e (Greifensee, Switzerland) instrument. 
Accurately weighed samples (2-3 mg) were placed in aluminium pans and sealed. 
Measurements were carried out under an atmosphere of dry nitrogen gas at a flow rate of             
50 mL/min using a heating rate of 10.0qC/min from 0qC to 180qC.  
Drug-polymer miscibility is related to the shift(s) in the melting endotherm or glass transition 
temperature of the drug [32]. Based on the Gordon-Taylor equation [24], if the drug and 
polymer are miscible then the mixture will show a single Tg that ranges between the Tg of the 
pure components and would depend on the relative proportion of each component. The Tg of 
the mixtures can be predicted using the Gordon-Taylor (GT) equation:  ܶ݉݅ݔ ൌ ݓ ? ൈ  ?൅ൈ ?ൈ ?ݓ ? ൅ ܭ ൈ ?  
Where, Tg is the glass transition temperature, w1 and w2 are the weight fractions of 
components and K is calculated from the densities (ȡ) and Tg of the amorphous components: ܭ ൌ ܶ ? ൈ ߩ ?ܶ ? ൈ ߩ ? 
2.4. X-ray powder diffraction 
XRPD was used to assess the crystalline state of the IND, the physical mixtures and the 
hot-melt extrudates. All formulations including pure IND, physical mixtures and extruded 
formulations were evaluated using a Bruker D8 (Karlsruhe, Germany) Advance instrument in 
theta±theta mode, using a Cu anode at 40 kV and 40 mA, parallel beam Goebel mirror, 0.2 
mm exit slit, LynxEye Position Sensitive Detector with 3q opening and LynxIris at 6.5 mm 
and sample rotation at 15 rpm. The samples were scanned from 2 to 40q 2-theta with a step 
size of 0.02q 2-theta and a counting time of 0.2 s per step; 176 channels active on the PSD 
resulting in a total counting time of 35.2 s per step. 
2.5. Near-infrared spectroscopy (NIR) 
Transmission and reflectance NIR spectra were continuously collected in-line and non-
invasively during hot-melt extrusion using a Fourier-Transform Antaris MX NIR analyser 
(Thermo Fisher Scientific, United Kingdom) equipped with a InGaAs detector, a quartz 
halogen lamp, and a fibre optic probe which was attached in the extrusion die. Spectra were 
collected every 1 min in the 10000-4000 cm-1 wavenumber region with a resolution of                
16 cm-1 and averaged over 32 scans. For each batch 20 spectra were recorded. A 
transmission probe was fitted at the end of the extruder orifice (die) and the reflectance probe 
was inserted in the first mixing zone of the extruder barrel (Fig. 2). 
NIR data analysis was performed by using RESULT Software (Version 3.0, Thermo 
Fisher Scientific, UK). Spectra collected in both diffuse reflectance and transmission modes 
usually require spectral pre-treatment before analysis. The degree of scattering depends on 
the wavelength of the incident radiation and the refractive index of the sample, which causes 
an uneven scatter over the whole spectrum. This can result in a baseline shift. Therefore, 
standard normal variate (SNV) correction was used before chemometric analysis of the 
spectra. Using SNV, unwanted scatter was removed from the raw spectra to prevent it from 
dominating over chemical information within the spectra. The result of SNV pre-processing 
was that each spectrum had the same offset and amplitude, eliminating differences in light 
scatter in the spectra from different samples, before developing the calibration model. 
Furthermore, second derivative pre-processing was undertaken after SNV correction. Second 
derivative NIR spectra magnify differences in spectral features, provide baseline 
normalisation and remove linear data offsets due to scattering effects and path length 
variation. For principal component analysis (PCA) and for the development of a partial least 
square (PLS) model, 10 spectra of each drug-polymer mixture were used. Prior to PCA and 
PLS, spectra were mean centred. The PLS model was developed by regressing the IND 
concentration (Y) versus the corresponding in-line collected spectra (X). The validated 
spectra were used to evaluate the predictive performance of the PLS model. 
 
2.6. Confocal Raman spectroscopy 
Raman mapping was performed using a Jobin/Yvon LabRam 320 instrument equipped 
with an Olympus microscope (Horiba, Japan) by means of a He-Ne ion laser (Ȝ = 632.8 nm) 
and 1800 l/nm. The experimental conditions were: 100 nm slit width, a 50× Microsoft 
objective and 0.2 s acquisition times. Each spectrum was the mean of two. The sample 
profiling was performed at step increments of 8 ȝP LQ WKH X±Y direction over an area of 
2000 [ȝP2. PCA was used for data analysis. Prior to the analysis, all spectra were base 
line corrected and normalised using the standard normal variate method (SNV) to avoid 
intensity deviation among the Raman spectra. The Raman chemical maps were constructed 
by using Solo + Mia software (Eigenvector, Research, Inc. Wenatchee, USA). 
 
2.7. In-vitro drug release studies 
The release profiles for IND (bulk and granules produced from the extruded sheets using 
a cutter mill) were obtained using a Varian 705 DS dissolution paddle apparatus (Varian Inc. 
North Carolina, US). The analysis was carried out using dosage forms containing 50 mg of 
IND, in 900 mL of dissolution medium maintained at 37.0±0.5°C and agitated at 100 rpm. A 
phosphate buffer solution pH 6.8 was used the dissolution medium. At pre-established time 
intervals 5 mL samples were withdrawn from the dissolution medium, filtered through a     
 ȝP mesh, and analysed using HPLC. All dissolution studies were performed in 
triplicate. 
 
2.8. HPLC analysis 
The release of IND, in the dissolution studies, was determined by using an Agilent 
Technologies HPLC 1200 series system equipped with a HICROM S50DS2, 5 µm x 150 mm 
x 4 mm column using a 20 µl injection volume and a detection wavelength of 298 nm. The 
mobile phase consisted of acetonitrile/water (1% acetic acid) (70:30 v/v). The flow rate was 
adjusted to 1.5 mL/min and the retention time of IND was about 4 min. A calibration curve 
for IND (10±50 µg/mL) was used to quantitate all the samples.  
 
3. Results and discussion 
3.1. Hot-melt extrusion process 
The objective of this study was to investigate, for the first time, the implementation of    
in-line transmission and reflectance NIR probes in order to understand the transformation of 
the API (IND), in the presence of the polymers, from a crystalline phase to an amorphous 
phase during HME processing. The use of an NIR transmission probe for in-line monitoring 
during HME has not been previously reported and in this case it was used to record the NIR 
signals from molecular solutions or amorphous solid dispersions. It is known that a drug-
polymer system is considered miscible if the difference between their solubility parameters is 
less than 7.0 MPa1/2 [25]. Binary blends with differences in solubility parameters higher than 
10 MPa1/2 are likely to be immiscible.  Maniruzzaman et al [10] showed that the solubility 
parameters for IND, VA64 and SOL are 22.84 MPa1/2, 19.63 MPa1/2 and 19.40 MPa1/2, 
respectively. The selection of the drug/polymer formulations was expected to show good 
compatibility as the solubility parameter differences between IND/VA64 and INS/SOL are 
3.21 MPa1/2 and 3.44 MPa1/2 respectively. Hence, glassy solutions were obtained during 
HME processing due to the excellent miscibility of IND with both polymers. Using a die 
orifice (Fig. 1A) with a 1 mm slit size, results in the production of IND/polymer extrudates in 
the form of transparent sheets (Fig. 1B). The sheet thickness was also 1 mm, which facilitated 
the monitoring process using the in-line NIR transmission probe. Formulations F1-F5 were 
extruded at various drug-polymer ratios using a constant, low screw speed (50 rpm) in order 
to gain a better understanding of the transformations in the crystallinity of the API. However, 
higher screw speeds were applied for formulations F6 and F7 in order to monitor NIR signal 
variations related to the screw speed. Heil et al., [26] observed that higher screw speeds result 
in greater variability in extrusion processing, whereas lower screw speeds provide better 
repeatability.  
 
3.2. X-ray powder diffraction (XRPD)  
XRPD analysis was performed in order to investigate the physical state of the bulk IND, 
drug±polymer physical mixtures and the hot-melt extruded samples. The data in Fig. 3A 
shows the diffractogram of bulk IND with distinct intensity peaks at 10.17°, 11.62°, 17.02°, 
DQGșYDOXHVZKHUHDVSXUe SOL and 
VA64 presented noisy signals due to their amorphous nature. The physical mixtures of IND 
formulations with both SOL and VA64 polymers showed lower intensity peaks suggesting 
that they remained in the crystalline state at 20-50% loading (Fig. S1). In contrast, no distinct 
intensity peaks were observed in the diffractograms of all the extruded formulations, even at 
high drug loading (Fig. 3B). The absence of high intensity IND peaks indicates the formation 
of a solid dispersion, where the drug is present in an amorphous state or molecularly 
dispersed into the polymer matrices. 
 
3.3. Differential scanning calorimetry 
Differential scanning calorimetry was also used to determine the physical state of IND 
within the extruded formulations and compared with those of the physical mixtures. As 
shown in the data in Fig. 4A the DSC thermograms of pure IND displayed sharp melting 
endothermic WUDQVLWLRQVDW&ǻ+ -J-1). The DSC thermograms of SOL and 
VA64 gave Tg values of 68.07°C and 104.99°C, respectively due to their amorphous nature 
(Fig. 4A). Interestingly, the thermograms of the physical mixtures of all IND/VA64 and 
IND/SOL formulations showed broad endothermic transitions (Fig. 4B-C). The absence of a 
sharp melting peak for IND in the physical mixtures suggests that the API is partially 
dissolved within the polymer matrices. This behaviour is attributed to the both SOL and     
VA64 acting as solubilizers for a wide range of water insoluble drugs [27]. 
 
However, a single Tg was observed in all thermograms for the extrudates indicating    
drug-polymer miscibility. According to the GT equation, when two components of a mixture 
are miscible the single Tg of the extruded materials should be located between their Tg values 
[33]. By using the Gordon-Taylor equation the theoretical Tg of the drug-polymer blends was 
estimated (Table 2). In addition, the presence of a single Tg in all extruded samples suggests 
that the IND is molecularly dispersed within the polymer matrices. The incorporation of IND 
in both polymers lowers the Tg and allows the polymer chain segments greater freedom due 
to the fact that IND acts as a plasticizer. ,QDGGLWLRQWKHFRPSDULVRQRIWKHH[SHULPHQWDO7J¶V
and those obtained by the GT equation revealed that IND acts as a plasticizer for SOL as the 
Tgs were found in ± between the drug and the polymer. It can be seen that the Tg decreases 
with the increase of IND concentrations. Similar results were obtained for the IND/VA64 
extudates which are in good agreement with previous studies [10, 33]. 
 
3.4. In-line NIR monitoring 
Off-line NIR spectra of bulk IND, SOL and VA64 and the physical mixtures of all 
formulations were measured in order to identify the characteristic bands attributed to the pure 
samples. Using both the in-line NIR transmission and reflectance probes the HME process 
was monitored for all of the IND formulations. The probes were placed in two different 
positions of the extruder barrel; with the reflectance NIR probe fitted into the first mixing 
zone of the barrel and the transmission NIR probes placed in the extruder exit die (Fig. 2). 
The rationale for using both probes was to provide a more detailed understanding of the drug 
transformations during extrusion. As the first mixing zone was near to the feed point, it was 
expected that the processed formulations would not have been fully melted in this particular 
zone of the extruder; and a significant IND amount remained in crystalline form. This 
allowed the spectra to be collected using the reflectance NIR probe in this zone as the mixture 
would still be reflective. On the other hand, the extrudates were converted to a transparent 
solution along the mixing zones 2-3 so the spectra were collected using a transmission NIR 
probe placed at the extruder die.  
Two additional formulations (F6 and F7) were extruded in order to identify the effect of 
screw speed on the extrusion process; screw speeds of 200 rpm and 400 rpm were applied 
during the IND/SOL (50/50, w/w) extrusion. Principal component analysis (PCA) was used 
to investigate whether or not NIR could be used to detect the results of changes in the screw 
speed of the extruder. PCA was applied over the 6500-5500 cm-1 spectral range to 50 spectra 
(10 spectra each from IND/SOL formulations, F3-F7) resulting in a model with two PCs 
covering nearly all the spectral variations (99.04%). The PC scores plot obtained using 
constant process parameters (F3 ± F5) and variable screw speeds (F6 and F7) are shown in 
Fig. 5. The PC scores plot clearly shows that the screw speed has a significant effect on the 
NIR spectra as samples were widely spread on the PC1 axis. This effect is attributed to the 
changes in the die pressure and torque when the screw speed is increased. For thixotropic and 
pseudoplastic polymers there is usually a liner relationship between the screw speed and 
torque or die pressure. Table 3 shows the monitoring of the torque and die pressure as a 
function of screw speed. It can be clearly seen that by increasing the screw speed from 50 
rpm to 400 rpm the torque increases from 8.8 Nm to 12.7 Nm, respectively. Similarly, the die 
pressure increases with the screw speed and thus affects the NIR recorded spectra. The 
second PC was then used to describe the variation in the IND concentration. Ellipses were 
drawn around points in the PC score plot corresponding to specific production runs at 
constant IND concentration. However, the ellipses were very similar in size, which indicated 
that screw speed had very little influence on the homogeneity of the extrudates. PCs model 
variance and the maximum variance is modelled in PC1, which usually explains more 
variation than PC2. This means that pressure (screw speed) has a bigger effect on the spectra 
than IND concentration. That is why extruder conditions have to be kept constant when using 
an NIR method as changes in processing conditions will have a large influence on the results. 
Two binary IND/SOL mixtures containing 20% and 40% IND respectively, were 
extruded under the same extrusion settings (50rpm screw speed, 145oC) to investigate the 
effect of drug concentration in the in ± line NIR spectra.  Fig. 6a shows the reflectance 
spectra of the bulk IND, the physical mixture, the processed mixture (Z1, 2nd barrel) and the 
transmission spectra of the IND/VA64 (20% and 40% loading) at the extrusion die. The 
spectral comparison of the IND/VA64 (40/60 w/w) clearly shows peak shifts, which suggest 
molecular interactions between the drug and the polymer.  The shift is smaller for the 
reflectance probe (5243 cm-1) in the first mixing zone (100oC) compared to the physical 
mixture  (5217 cm-1) as IND is still crystalline and not fully transformed to amorphous. The 
use of the transmission probe in the third mixing zone showed further peak shifts (5251 cm-1) 
where IND was molecularly dispersed within the polymer matrix.  In addition, the increase of 
IND concentration resulted in larger shifts and higher intensity peaks. The increase of the 
intensity demonstrates the plasticization effect of IND, which leads to the formation of 
stronger, and more drug±polymer intermolecular bonds. Similar results can be observed in 
Fig. 6b where the increase of IND concentration in the IND/SOL mixtures presented 
significant peak shifts with increased peak intensities. Hence, the IND/SOL (50:50 w/w) 
extrudates showed the highest peak intensity (4690 cm-1) compared to the 40/60 w/w (4682 
cm-1) and 20/80 wt/wt (4664 cm-1) extrudates respectively.  
Furthermore, Fig. S2 shows a new peak with high intensity was found at 7100cm-1 in the 
all IND/SOL extrudates, which is attributed to the±OH first overtone stretch. The peak does 
not appear in the physical mixtures and it is probably due to the H-bonding between the ±
COOH of IND and the ±OH of SOL. The polymer has an ±OH absorption peak at 7034cm-1, 
which shifts to 7100cm-1 due to the intermolecular interactions of the drug/polymer 
functional groups.  
In Fig. S3(a,b) the NIR spectrum of IND shows a well-defined and intense peak at 6020cm-1 
and similar peaks appear across the whole spectrum.  However, all extruded IND/SOL 
formulations showed quite broad and less defined peaks at the third mixing zone for the 
spectra recorded with the transmission probe. According to previous studies [17, 23] the 
presence of broad peaks suggests that IND is transformed to an amorphous form and the 
molecule is not present in a crystalline long-range three-dimensional order. The peak 
intensity and position of the spectra of the physical mixture shows no drug ± polymer 
interactions which suggests that the drug transformation was effectively achieved during the 
HME processing.  
The NIR data are in good agreement with the DSC thermograms and XRPD 
diffractograms obtained for the extrudates. The use of the transmission NIR probe was 
proved helpful in monitoring the HME processing of molecularly dispersed IND/SOL and 
IND/VA64 that are in the form of clear and transparent extrudates. The use of the reflectance 
NIR probe for in-line monitoring of such extrudates would be very difficult, because of the 
high noise signals produced.  
 
3.5. Confocal Raman spectroscopy 
The data in Fig. 7 illustrates the Raman spectra of the pure compounds. Most of the 
Raman bands overlap or can be potentially overlapped in the extrudates due to the chemical 
environment. Hence, for example, the Raman bands of IND in the 1500-1720 cm-1 
wavenumber region, which correspond to C=O stretching, are overlapped with the broad 
bands of VA64 at 1650 and 1750 cm-1. Therefore, multivariate data analysis (namely PCA) 
which takes into account the whole spectrum was applied. The method does not require the 
pure spectra of the compounds which can change in the formulations due to molecular 
interactions. In PCA, the spectra are decomposed into principal components that reflect 
variations amongst the spectra. In principle, the Raman hyperspectral data set can be 
described as a linear combination of a small number of components and hence instead of 
observing the distribution of a particular band, the distribution of the entire spectrum which 
corresponds to a particular component is obtained.  
The data in Fig. 8 shows the first principal component spectrum and the 
corresponding concentration map for the extruded IND/VA64 sample. The hyperspectral 
Raman data were decomposed into three PCs. There are various methods which can be used 
to determine the number of components present in PCA [31, 32]. The most common 
approach is the analysis of eigenvalues and by monitoring the values of the associated scores 
and loadings. It is quite likely that there are only two components present (Fig. 9a); which is 
expected as there are only two compounds present. This can be clearly confirmed by plotting 
the first three PCs where only the first PC has identifiable bands. The 2nd and 3rd PCs contain 
noise and the bands are too broad to extract any useful information (Fig. 8b). The first 
loading spectrum contains characteristic bands for both IND and VA64. It is worth 
mentioning that the carbonyl band of IND at 1710 cm-1 moves towards a lower wavenumber 
(Fig. 8c) indicating stronger interactions of the C=O group. It is possible for the carbonyl 
groups of IND to interact with the OH groups of other IND molecules via hydrogen bonding. 
In the amorphous state these interactions are stronger than in crystalline powder resulting in 
the movement of the C=O band to lower wavenumbers. Also, previous studies showed that 
the Raman bands of amorphous IND become broader [31] resulting in an overlap with the 
bands of VA64 rendering the analysis even more difficult (Fig. 8b). The concentration map 
for PC1 (Fig. 8d) shows the homogeneous distribution of the compounds. 
 
3.6. In-vitro drug release studies 
In-vitro drug release studies were performed in order to investigate the dissolution 
patterns of the extruded samples and the bulk IND. The particle size of the extruded granules 
did not have an effect on the dissolution profiles. The extruded sheets were passed through a 
cutter mill and all batches presented similar particle size distribution (Fig. S4). The 
dissolution profiles of bulk IND and extruded formulations with the highest IND loadings for 
VA64 and SOL are shown in Fig. 9. Due to low water solubility, the bulk IND powder 
showed very low dissolution rates compared with extruded formulations. IND/VA64 
extrudates at 40:60 (w/w) ratios displayed a rapid dissolution rate, with 80% of the IND being 
released in 15 min while complete IND release was detected at 30 min. For the extruded 
IND/SOL granules 30% of the IND was released in the first 20 min and approximately 55% 
after 30 min. More than 80% IND was released after 90 min from the IND/SOL (50:50 w/w) 
extrudates. The dissolution studies (Fig. S5) revealed faster IND release rates with increasing 
loadings for both polymers due to stronger drug/polymer interactions [33]. However, 
dissolution studies performed at pH 1.2 showed negligible amount of IND release after 2 hr, 
the findings are in agreement with the previous studies [27].  
 
4. Conclusions 
In this study, in-line transmission and reflectance NIR probes were employed as PAT 
tools for monitoring the HME processing of IND/ SOL and IND/VA 64 extrudates. By using 
both the NIR probes it was possible to monitor the transformation of IND from the crystalline 
to molecularly dispersed state during the extrusion processing. DSC and XRPD analysis of 
the extruded IND/VA64 and IND/SOL sheets confirmed the plasticizing effect of IND and 
the manufacture of solid solutions with IND being molecularly dispersed in the polymer 
matrices. The PCA plots obtained from the NIR transmission spectra showed that a change in 
the screw speed of the extruder resulted in different NIR spectra due to the increased pressure 
at the die. The transmission probe also helped to identify stronger drug-polymer interactions 
with increasing drug concentrations, the formation of H-bonding between their functional 
groups and IND transformation to a molecular solution within the polymer matrix. Confocal 
Raman spectroscopic data was used to show the homogeneity of the IND/polymer extruded 
sheets. In conclusion, the use of a transmission NIR probe proved to be a valuable PAT tool 
for monitoring and process understanding of HME solid dispersions.  
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